繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Bioceres报告第三季度业绩

2025-05-21 19:06

  • Bioceres press release (NASDAQ:BIOX): Q3 net loss was $1.6 million
  • Revenue of $60.6M (-27.9% Y/Y).
  • Total revenues were $60.6 million in 3Q25, compared to $84.0 million for the same quarter last year, primarily due to an expected $15.7 year-over-year negative difference related to the accrual in 3Q24 of Syngenta’s initial downpayment.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。